The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidn...
The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study
About this item
Full title
Author / Creator
Yang, Hao , Yang, Lili , Jardine, Meg J. , Arnott, Clare , Neuen, Brendon L. , Xu, Kexi , Zhao, Xiaohui , Qian, Dehui , Cui, Bin , Qiu, Youzhu , Huang, Yuli , Yu, Jie , Wang, Jiang , Yu, Shiyong , Tan, Hu , Huang, Lan , Li, Jing-Wei and Jin, Jun
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been proven to prevent decline in kidney function and failure. Whether SGLT2i affect the risk of contrast-associated acute kidney injury (CA-AKI) remains uncertain.
Use of SGLT2i was assessed in consecutive diabetics undergoing coronary angiography (CA) or percutaneous coronary intervention...
Alternative Titles
Full title
The association between sodium–glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e423ff0c66594a81979012ecbba7b957
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e423ff0c66594a81979012ecbba7b957
Other Identifiers
ISSN
2047-783X,0949-2321
E-ISSN
2047-783X
DOI
10.1186/s40001-024-02214-7
